Aug 24, 2026
Pfizer (PFE) Stock: Analysts Lean Bullish Despite Lingering Valuation Questions
Pfizer (PFE) stock trades at 9.4x 2026 earnings with a 6.1% dividend yield. Wall Street says Moderate Buy, but valuation questions persist.
The post Pfizer (PFE) Stock: Analysts Lean Bullish Despite Lingering Valuation Questions appeared first on Blockonomi.
Source: Blockonomi →Related News
- 2 hours ago
Coherent Corp. (COHR) Stock: Surge as New 6.4T Optics Boost AI Growth Outlook
- 2 hours ago
International Business Machines Corporation (IBM) Stock: New Study Reveals AI Wo...
- 2 hours ago
GRAIL (GRAL) Stock Surges 22% Before Critical FDA Panel Meeting on Galleri Test
- 2 hours ago
Solidion Technology (STI) Stock: Climbs as CEO Jaymes Winters Adds Chairman Role
- 2 hours ago
Accenture (ACN) Stock Surges 6% Following $2B Anthropic AI Safety Deal